Blastic plasmacytoid dendritic cell neoplasm (BPDCN): international, multi-center collaboration and global registry program

Overview of attention for article published in Discover Oncology, December 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet

twitter: 7 X users

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 3 news stories from 1 outlets.

Jemma Arakelyan: Welcoming Physicians and Centers Managing BPDCN to Join Our Registry - OncoDaily

Oncodaily, 23 Apr 2026

Jemma Arakelyan, Chief Executive Officer at The Institute of Cancer and Crisis (ICC) and Medical Advisor at Immune Oncology…

Gevorg Tamamyan: Data From 36 Patients Across 12 Countries - A Meaningful Start for BPDCN - OncoDaily

Oncodaily, 03 Jan 2026

Gevorg Tamamyan, Co-Founder and Editor-in-Chief of OncoDaily, President of SIOP Asia Continental Branch, and Pediatric Oncology…

Naveen Pemmaraju: Bringing More Global Awareness and a New International Collaboration for BPDCN - OncoDaily

Oncodaily, 24 Dec 2025

Naveen Pemmaraju/youtube.com and Astghik Voskanyan/immonc.org Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.